SBI Holdings Inc 2016 AR2
The report outlines the SBI Group's strategic transition into a new growth phase focused on FinTech, blockchain, and biotechnology for the fiscal year ended March 31, 2016. Key highlights include achieving record-high consolidated revenue of 261.7 billion yen and establishing the FinTech Fund with a 30 billion yen commitment to drive financial innovation. The group also expanded its biotechnology-related business through the acquisition of photonamic, a German pharmaceutical company, to globally develop its 5-ALA-related business. Additionally, the report details the group's corporate governance enhancements, human resource development initiatives, and direct social contributions through the SBI Children's Hope Foundation.
Company: SBI Holdings Inc
Sector: Financials
Country: Japan
Year: 2016
Type: AR2
Pages: 106
SBI Holdings Inc
The report outlines the SBI Group's strategic transition into a new growth phase focused on FinTech, blockchain, and biotechnology for the fiscal year ended March 31, 2016. Key highlights include achieving record-high consolidated revenue of 261.7 billion yen and establishing the FinTech Fund with a 30 billion yen commitment to drive financial innovation. The group also expanded its biotechnology-related business through the acquisition of photonamic, a German pharmaceutical company, to globally develop its 5-ALA-related business. Additionally, the report details the group's corporate governance enhancements, human resource development initiatives, and direct social contributions through the SBI Children's Hope Foundation.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Apr 1, 2015 - Mar 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management
Employees